Sat, Aug 23, 2014, 3:11 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation (GERN) Message Board

  • afewminutes21 afewminutes21 Dec 19, 2013 10:10 PM Flag

    Geron and Boardwalk Empire

    Gaston Means to undercover FBI agent Tolliver in a recent episode of "Boardwalk Empire": "The best predictor of future behavior is past behavior." John Chip Scarlett's past behavior:

    Sensus Drug Development Corportion
    1992 – 2001 Austin, TX
    As Founder and CEO, led the Company through a key partnership with Genentech, the acquisition, development and approval of an endocrine product, SOMAVERT® (pegvisomant), and the sale of the Company to Pharmacia in 2001.

    Covance Biotechnology Services, Inc.
    1993 – 2001 Research Triangle Park, NC
    Founder & Director - Developed the business plan and negotiated a joint venture with Corning, Inc., directed site selection and construction of a state-of-the-art, process development and recombinant protein cGMP manufacturing facility in RTP, and as a Director, provided Board oversight for a 450 employee business with multiple large pharmaceutical company clients prior to its sale to Akzo Nobel’s Diosynth Division in 2001.

    Tercica, Inc.
    2001 – 2008 Brisbane, CA
    As Co-Founder and CEO, led the Company through the acquisition, approval and commercialization of two novel endocrine products (INCRELEX® and SOMATULINE® DEPOT), key partnerships with Genentech and Ipsen S.A., and multiple financing rounds including the IPO in 2004 and subsequent follow-on equity offerings. Tercica merged with Ipsen in the 4th quarter of 2008 in a transaction that valued the company at approximately $660 million.

    Proteolix, Inc.
    2009 – 2010 South San Francisco, CA
    As President and CEO led Proteolix, a biotechnology company developing proteasome inhibitors (including carfilzomib) for oncology and immunology applications, through a management realignment and subsequent merger with Onyx Pharmaceuticals (NASDAQ: ONXX) valued at $856 million.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ....well you certainly dug up the CV goods on Chippy. That guy reads like a used pharma salesman in a white polyester lab coat. So it's a buyout again.
      Now for the secondary that apparently wasn't exercised recently in that 100mil share turnover game. Wonder if that had anything to do with a potential buyer? INCY must be getting antsy. Maybe the shelf is GERN's poison pill threat to stop any hostile takeovers

 
GERN
2.320.00(0.00%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.